Shopping Cart 0
Cart Subtotal
USD 0

Starpharma Holdings Ltd (SPL) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Starpharma Holdings Ltd (SPL)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Starpharma Holdings Ltd (Starpharma) is a biotechnology company, which researches, develops and manufactures dendrimer products for pharmaceutical, life sciences and other applications. Dendrimers are synthetic nanoscale polymers with pharmaceutical and medical uses. The company's development programs include its DEP drug delivery, which is built around dendrimers, VivaGel portfolio and agrochemicals. Its flagship product candidate, VivaGel, is a gel-based formulation for the treatment and prevention of bacterial vaginosis (BV) and it is also used as a vaginal microbicide to prevent sexually transmitted infections including HIV and genital herpes. The company has license arrangements with several partners including Ansell Limited, Aspen Pharmacare, Okamoto Industries and AstraZeneca. The company has research facilities in Melbourne, Australia. Starpharma is headquartered in Melbourne, Australia.

Starpharma Holdings Ltd Key Recent Developments

Aug 21,2018: Starpharma: Annual report and financial results for the year ended 30 June 2018

Feb 26,2018: Starpharma Interim Report and Half-Year Financial Results

Oct 09,2017: Starpharma and Peter Mac Cancer Centre awarded DEP Grant

Aug 28,2017: Starpharma annual report and full year financial results

Jun 30,2017: MIPS and Starpharma awarded STEM+ Business Fellowships to further targeted delivery technologies for cancer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Starpharma Holdings Ltd-Key Facts 5

Starpharma Holdings Ltd-Key Employees 6

Starpharma Holdings Ltd-Key Employee Biographies 7

Starpharma Holdings Ltd-Major Products and Services 8

Starpharma Holdings Ltd-History 9

Starpharma Holdings Ltd-Company Statement 12

Starpharma Holdings Ltd-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2-Company Analysis 15

Company Overview 15

Starpharma Holdings Ltd-Business Description 16

Starpharma Holdings Ltd-Corporate Strategy 17

Starpharma Holdings Ltd-SWOT Analysis 18

SWOT Analysis-Overview 18

Starpharma Holdings Ltd-Strengths 18

Starpharma Holdings Ltd-Weaknesses 19

Starpharma Holdings Ltd-Opportunities 20

Starpharma Holdings Ltd-Threats 21

Starpharma Holdings Ltd-Key Competitors 22

Section 3-Company Financial Ratios 23

Financial Ratios-Capital Market Ratios 23

Financial Ratios-Annual Ratios 24

Performance Chart 26

Financial Performance 26

Financial Ratios-Interim Ratios 27

Financial Ratios-Ratio Charts 28

Section 4-Company's Lifesciences Financial Deals and Alliances 29

Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Starpharma Holdings Ltd, Recent Deals Summary 31

Section 5-Company's Recent Developments 32

Aug 21, 2018: Starpharma: Annual report and financial results for the year ended 30 June 2018 32

Aug 21, 2018: Starpharma: Annual report and financial results for the year ended 30 June 2018 33

Aug 21, 2018: Starpharma: Annual report and financial results for the year ended 30 June 2018 34

Aug 21, 2018: Starpharma: Annual report and financial results for the year ended 30 June 2018 35

Feb 26, 2018: Starpharma Interim Report and Half-Year Financial Results 36

Oct 09, 2017: Starpharma and Peter Mac Cancer Centre awarded DEP Grant 38

Aug 28, 2017: Starpharma annual report and full year financial results 39

Jun 30, 2017: MIPS and Starpharma awarded STEM+ Business Fellowships to further targeted delivery technologies for cancer 41

Section 6-Appendix 42

Methodology 42

Ratio Definitions 42

About GlobalData 46

Contact Us 46

Disclaimer 46


List Of Figure

List of Figures

Starpharma Holdings Ltd, Performance Chart (2014-2018) 26

Starpharma Holdings Ltd, Ratio Charts 28

Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30


List Of Table

List of Tables

Starpharma Holdings Ltd, Key Facts 5

Starpharma Holdings Ltd, Key Employees 6

Starpharma Holdings Ltd, Key Employee Biographies 7

Starpharma Holdings Ltd, Major Products and Services 8

Starpharma Holdings Ltd, History 9

Starpharma Holdings Ltd, Subsidiaries 14

Starpharma Holdings Ltd, Key Competitors 22

Starpharma Holdings Ltd, Ratios based on current share price 23

Starpharma Holdings Ltd, Annual Ratios 24

Starpharma Holdings Ltd, Annual Ratios (Cont...1) 25

Starpharma Holdings Ltd, Interim Ratios 27

Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Starpharma Holdings Ltd, Recent Deals Summary 31

Currency Codes 42

Capital Market Ratios 42

Equity Ratios 43

Profitability Ratios 43

Cost Ratios 44

Liquidity Ratios 44

Leverage Ratios 45

Efficiency Ratios 45

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Starpharma Holdings Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Sanonda Australia Pty Ltd

ResApp Health Ltd

Proudex Australia Pty Ltd

iNova Pharmaceuticals (Australia) Pty Ltd

Immuron Ltd

GLYDE Health Pty Ltd

Starpharma Holdings Ltd (SPL)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Starpharma Holdings Ltd (Starpharma) is a biotechnology company, which researches, develops and manufactures dendrimer products for pharmaceutical, life sciences and other applications. Dendrimers are synthetic nanoscale polymers with pharmaceutical and medical uses. The company's development programs include its DEP drug delivery, which is built around dendrimers, VivaGel portfolio and agrochemicals. Its flagship product candidate, VivaGel, is a gel-based formulation for the treatment and prevention of bacterial vaginosis (BV) and it is also used as a vaginal microbicide to prevent sexually transmitted infections including HIV and genital herpes. The company has license arrangements with several partners including Ansell Limited, Aspen Pharmacare, Okamoto Industries and AstraZeneca. The company has research facilities in Melbourne, Australia. Starpharma is headquartered in Melbourne, Australia.

Starpharma Holdings Ltd Key Recent Developments

Aug 21,2018: Starpharma: Annual report and financial results for the year ended 30 June 2018

Feb 26,2018: Starpharma Interim Report and Half-Year Financial Results

Oct 09,2017: Starpharma and Peter Mac Cancer Centre awarded DEP Grant

Aug 28,2017: Starpharma annual report and full year financial results

Jun 30,2017: MIPS and Starpharma awarded STEM+ Business Fellowships to further targeted delivery technologies for cancer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Starpharma Holdings Ltd-Key Facts 5

Starpharma Holdings Ltd-Key Employees 6

Starpharma Holdings Ltd-Key Employee Biographies 7

Starpharma Holdings Ltd-Major Products and Services 8

Starpharma Holdings Ltd-History 9

Starpharma Holdings Ltd-Company Statement 12

Starpharma Holdings Ltd-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2-Company Analysis 15

Company Overview 15

Starpharma Holdings Ltd-Business Description 16

Starpharma Holdings Ltd-Corporate Strategy 17

Starpharma Holdings Ltd-SWOT Analysis 18

SWOT Analysis-Overview 18

Starpharma Holdings Ltd-Strengths 18

Starpharma Holdings Ltd-Weaknesses 19

Starpharma Holdings Ltd-Opportunities 20

Starpharma Holdings Ltd-Threats 21

Starpharma Holdings Ltd-Key Competitors 22

Section 3-Company Financial Ratios 23

Financial Ratios-Capital Market Ratios 23

Financial Ratios-Annual Ratios 24

Performance Chart 26

Financial Performance 26

Financial Ratios-Interim Ratios 27

Financial Ratios-Ratio Charts 28

Section 4-Company's Lifesciences Financial Deals and Alliances 29

Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Starpharma Holdings Ltd, Recent Deals Summary 31

Section 5-Company's Recent Developments 32

Aug 21, 2018: Starpharma: Annual report and financial results for the year ended 30 June 2018 32

Aug 21, 2018: Starpharma: Annual report and financial results for the year ended 30 June 2018 33

Aug 21, 2018: Starpharma: Annual report and financial results for the year ended 30 June 2018 34

Aug 21, 2018: Starpharma: Annual report and financial results for the year ended 30 June 2018 35

Feb 26, 2018: Starpharma Interim Report and Half-Year Financial Results 36

Oct 09, 2017: Starpharma and Peter Mac Cancer Centre awarded DEP Grant 38

Aug 28, 2017: Starpharma annual report and full year financial results 39

Jun 30, 2017: MIPS and Starpharma awarded STEM+ Business Fellowships to further targeted delivery technologies for cancer 41

Section 6-Appendix 42

Methodology 42

Ratio Definitions 42

About GlobalData 46

Contact Us 46

Disclaimer 46


List Of Figure

List of Figures

Starpharma Holdings Ltd, Performance Chart (2014-2018) 26

Starpharma Holdings Ltd, Ratio Charts 28

Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30


List Of Table

List of Tables

Starpharma Holdings Ltd, Key Facts 5

Starpharma Holdings Ltd, Key Employees 6

Starpharma Holdings Ltd, Key Employee Biographies 7

Starpharma Holdings Ltd, Major Products and Services 8

Starpharma Holdings Ltd, History 9

Starpharma Holdings Ltd, Subsidiaries 14

Starpharma Holdings Ltd, Key Competitors 22

Starpharma Holdings Ltd, Ratios based on current share price 23

Starpharma Holdings Ltd, Annual Ratios 24

Starpharma Holdings Ltd, Annual Ratios (Cont...1) 25

Starpharma Holdings Ltd, Interim Ratios 27

Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Starpharma Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Starpharma Holdings Ltd, Recent Deals Summary 31

Currency Codes 42

Capital Market Ratios 42

Equity Ratios 43

Profitability Ratios 43

Cost Ratios 44

Liquidity Ratios 44

Leverage Ratios 45

Efficiency Ratios 45

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Starpharma Holdings Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Sanonda Australia Pty Ltd

ResApp Health Ltd

Proudex Australia Pty Ltd

iNova Pharmaceuticals (Australia) Pty Ltd

Immuron Ltd

GLYDE Health Pty Ltd